Nuclear Medicine Research
6 comprehensive market analysis studies and research reports on the Nuclear Medicine sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 66 companies, enriched with industry statistics, insights, and a lot more.
Healthcare
Categories
6 Healthcare Reports
Categories
Filters and Sort
Showing 6 of 6 results in Nuclear Medicine
Nuclear Medicine Radioisotopes Market
CAGR: 10.78%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, South America, Middle East and Africa
Major Players:Eckert & Ziegler AG, Sotera Health Company (Nordion Inc.), NECSA Ltd. (NTP Radioisotopes SOC Ltd.), NorthStar Medical Radioisotopes LLC, IRE ELiT
North America Nuclear Medicine Market
CAGR: 7.10%
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, North America
Major Players:Cardinal Health, Sotera Health, Curium Pharma, GE Healthcare, Siemens Healthineers
Nuclear Medicine Market
CAGR: 12.45%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:GE Healthcare, Curium Pharma, Cardinal Health, Bayer, Siemens Healthineers
Asia-Pacific Nuclear Medicine Market
CAGR: 12.77%
Study Period: 2019 - 2030
Countries Covered: China, Japan, India, Australia, South Korea, Asia
Major Players:GE Healthcare, Seimens Healthineers, Curium Pharma, Telix Pharmaceuticals, China Isotope & Radiation Corp. (CIRC)
Nuclear Medicine Therapeutics Market
CAGR: 19.78%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Bayer, Curium Pharma, Lantheus Holdings, Novartis, Telix Pharmaceuticals
Europe Nuclear Medicine Market
CAGR: 10%
Study Period: 2019 - 2030
Countries Covered: Germany, United Kingdom, France, Italy, Spain, Europe
Major Players:Cardinal Health, Curium Pharma, GE Healthcare, Novartis, Siemens Healthineers
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
